Profit Royal Pharmaceutical Ltd.
NASK was Established in 2015 by Profit Royal Pharmaceutical Limited, NASK is the pioneer of revolutionizing and commercializing the use of nanofibers. Our inventions include NASK Nanofiber, a patented and award-winning innovative material. NASK has recently implemented our cutting-edge nanofibers technology in respirators, which have been instrumental in safeguarding our community throughout the COVID-19 pandemic. The NASK Respirator is the world’s first nanofiber respirator which has been fully certified by the US National Institute for Occupational Safety & Health (NIOSH).
NASK SM-N9501 is NIOSH-approved and CDC-approved (approval number 84A-7761) particulate respirators designed to be effective against particulate aerosols free of oil with a 95% filter efficiency level. NASK N95 mask can kill over 99% of Bacteria within 5 minutes. Strong protection against germs, bacteria and smog, suitable for medical, health care centers and highly polluted environment.
Case, Sample-one box
L, M, S